Are you an academic researcher looking for cutting-edge drug discovery tools? Join our Academic Access Program!

HiBiT-Powered CRISPR Knock-Ins for Endogenous Tagging

One Tiny Tag, Big Impact

CRISPR/Cas9 knock-in of the small, powerful HiBiT tag lets researchers study proteins in their native cellular context. Because it avoids overexpression and antibody-based detection, it preserves natural regulation and delivers more accurate, reproducible, and biologically meaningful data through simple, scalable bioluminescent detection.

  • Precise quantification: Measure protein abundance with endpoint or live-cell kinetic methods to see how proteins respond to changing conditions or compound treatment.
  • Broad compatibility: Works with detection of surface-expressed and secreted proteins.
  • Flexible downstream analysis: A sensitive, high-affinity anti-HiBiT monoclonal antibody supports traditional immunoassays, including Western blots and immunoprecipitation.

Our CRISPR/Cas9 knock-in cell lines support a wide range of applications in drug discovery and functional biology, including:

  • Receptor internalization: track movement of membrane proteins and their regulation in live cells.
  • Downstream signaling: measure how protein activity influences broader pathways.
  • Targeted protein degradation: monitor degrader activity, kinetics and compound potency in real time.

Watch this video for an introduction to HiBiT

Getting Started with CRISPR/Cas9 Knock-In Cell Lines

Choosing a workflow for CRISPR-enabled endogenous biology experiments will depend on the type of experiment, laboratory resources and experience, and the project timeline. Get started quickly by taking advantage of our collection of 250+ CRISPR-knock-in cell line pools and clones, available for a variety of target proteins and cell backgrounds. If you need to create custom knock-in cells, you have options. Check out the detailed protocol and access the HiBiT sequence. Need guidance? Reach out to one of our experts to ensure you get the results you need. Or, connect with a licensed service provider to explore custom knock-in cell generation options.

Choose the Path that Best Meets Your Needs

Pre-Built Cell Lines and Pools
Custom Cell Line and Pool Options
cart


 

Check out our comprehensive list of 250+ cell line pools and clones for popular targets and cell backgrounds.

View Cell Lines

tool


cart


Build it yourself

 

Use our detailed protocol to create your own HiBiT knock-in cells. Obtain the HiBiT sequence and synthesis rights and review our terms of use by completing our licensing agreement.

View Detailed Protocol

View Licensing Agreement

Connect with a licensed provider

 

Collaborate with experts who offer custom knock-in and gene-editing services:

EditCo Bio – Provides functionally validated CRISPR-edited cell lines, offering precise and scalable genome engineering solutions to support research in cell and gene therapy, drug discovery, and basic biology.

FUJIFILM CDI – Offers custom knock-in cell line generation using human iPSC-derived cells to create physiologically relevant models for disease research, drug discovery, and cell therapy development.

ALSTEM, Inc. – Delivers custom iPSCs, CRISPR/Cas9-edited cell lines, and viral vectors, supporting research in regenerative medicine, disease modeling, drug discovery, and basic biology.

Why Choose HiBiT for CRISPR Knock-In Experiments?

HiBiT knock-in tagging combines the precision of CRISPR with the sensitivity of bioluminescence. By inserting HiBiT directly into the genome, you can:

  • Monitor physiological expression to avoid gene dosage effects and artifacts from overexpression.
  • Study genes under natural promoter and epigenetic control.
  • Maintain protein balance by preserving natural ratios with interacting partners.
  • Generate knock-in models faster as no molecular cloning is required.

What is HiBiT?

The Benefits of Endogenous Tagging
tagging endogenous loci using crispr knock-in method

Hear from a Scientist

Discover how researchers like Dan Nomura, Ph.D. from University of California - Berkeley are using HiBiT-powered CRISPR knock-ins to study protein dynamics at endogenous levels.

Endogenous Tagging Reveals True Protein Activity

When studying a protein, an ideal approach would be to measure its activity with as little interference as possible. Researchers will typically overexpress the protein or use transient expression to observe it easier, but this can result in challenges. When protein levels exceed the capacity of endogenous regulatory machinery, stoichiometry can break down, binding partners become saturated, and assay windows change in ways that don't translate to the true protein activity. Tagging proteins at their endogenous locus with CRISPR/Cas9 alleviates these concerns.

Endogenous Tagging Creates an Improved Assay Window for BRD4 Degradation Assay

Protein levels shift with cellular conditions or therapeutic interventions, such as protein degrader treatments, making sensitive assays essential.

In this example, knock-in cells provided an increased assay window when compared to higher level overexpression models, highlighting the advantage of monitoring native expression.

 

View White Paper
14286MB

CRISPR knock-in of HiBiT at the BRD4 locus was used to measure protein abundance following treatment with the dBET1 degrader. BRD4 under native regulation was compared with different dilutions of CMV or TK-driven overexpression. Cells were treated with a titration of dBET1 and protein abundance was measured by quantifying the HiBiT tag (using the Nano-Glo® HiBiT Lytic Detection System).

Endogenous Target Expression Reveals Degrader Activity Missed by Ectopic Overexpression

Using endogenous target expression in degrader screens can reveal degraders that may be missed by ectopic overexpression models.

Transient Target Expression

19873ma

Endogenous Target Expression

19872ma

Cells expressing transiently overexpressed TK-NL-BRD7 (left) or endogenous BRD7 (right) were treated with the indicated compounds or DMSO control, and luminescent signal was monitored over 25 hours. The endogenous expression panel revealed degradation activity for multiple compounds (e.g., VZ95, VZ207, VZ221) that appeared inactive in the ectopic system, demonstrating that overexpression models can mask moderate degraders and lead to false negatives during screening.

Interested in more physiologically relevant research tools?

Explore our full portfolio of tools for detecting biologically relevant protein dynamics and cellular activity.

Explore Tools